
The US CDC reported 3,437 Candida auris cases across 27 states by 25 July, according to LiveMint. This was about 1,000 fewer than the same period last year, although annual case numbers continue to rise more slowly than before. California, Texas and Tennessee recorded the highest counts. The fungus mainly spreads in healthcare facilities and affects seriously ill or immunocompromised people.
The Economic Times reported 3,130 confirmed cases across 23 states by 18 July, with Texas and Michigan recording the highest numbers. The differing totals may reflect different reporting dates or datasets. Candida auris can resist several antifungal medicines and routine disinfectants. Echinocandins remain effective, while estimated mortality is difficult to assess because many patients have other serious illnesses.
Candida auris warrants careful monitoring, especially in hospitals and among patients with weakened immunity. However, describing it as uniformly deadly or suggesting an immediate public threat would go beyond the available evidence. The lower year-to-date figure reported by LiveMint does not remove concerns about resistance and continuing annual increases. The differing figures in the two reports also show why current, clearly dated surveillance data matter.
Sources (2): livemint.com, economictimes.indiatimes.com
This story was synthesised by AI from the 2 sources linked above.